Risk of SARS-CoV-2 testing, PCR-confirmed infections and COVID-19--related hospital admissions in children and young people: birth cohort study

Abstract

BackgroundThere have been no population-based studies of SARS-CoV-2 testing, PCR-confirmed infections and COVID-19-related hospital admissions across the full paediatric age range. We examine the epidemiology of SARS-CoV-2 in children and young people (CYP) aged <23 years.MethodsWe used a birth cohort of all children born in Scotland since 1997, constructed via linkage between vital statistics, hospital records and SARS-CoV-2 surveillance data. We calculated risks of tests and PCR-confirmed infections per 1000 CYP-years between August and December 2020, and COVID-19-related hospital admissions per 100,000 CYP-years between February and December 2020. We used Poisson and Cox proportional hazards regression models to determine risk factors.ResultsAmong the 1226855 CYP in the cohort, there were 378402 tests, 19005 PCR confirmed infections and 346 admissions, corresponding to rates of 770.8/1000 (95% confidence interval 768.4-773.3), 179.4 (176.9-182.0) and 29.4/100,000 (26.3-32.8) CYP-years respectively. Infants had the highest COVID-19-related admission rates. Chronic conditions, particularly multiple types of conditions, was strongly associated with COVID-19-related admissions across all ages. The hazard ratio for >1 chronic condition type was 12.2 (7.9-18.82) compared to children with no chronic conditions. 89% of admitted children had no chronic conditions recorded.ConclusionsInfants, and CYP with chronic conditions are at highest risk of admission with COVID-19, however the majority of admitted CYP have no chronic conditions. These results provide evidence to support risk/benefit analyses for paediatric COVID-19 vaccination programmes. Studies examining whether maternal vaccine during pregnancy prevents COVID-19 admissions in infants are urgently needed.FundingUK Research and Innovation-Medical Research Council

Attitude and Level of COVID-19 Vaccination among Women in Reproductive Age during the Fourth Pandemic Wave: A Cross-Sectional Study in Poland

“…Unlike the early waves of the COVID-19 pandemic, in the fourth wave, the age of those infected fell sharply, including infants and young children. In addition, children below 2 years are at the greatest risk of developing acute symptoms [ 33 ] as well as long-term consequences, including PIMS-TS (pediatric inflammatory syndrome temporally associated with SARS-CoV-2) and MIS-C (multisystem inflammatory syndrome related to COVID-19). Unfortunately, there are currently no available vaccines for children under 5 years of age.…”

The Influence of Molecular Hydrogen Therapies in Managing the Symptoms of Acute and Chronic COVID-19

“…10 The pervasiveness of this condition, although problematic to diagnose due to lack of positive serological evidence of infection, is higher in nosocomial patients (87%) than in outpatients (35%), 10 suggesting that clinical renascence is likely to be associated with the asperity of primary disease. Moreover, in the general population, the lasting residuum of COVID-19 is estimated to be 4.4% in children, 11 10% in adults aged 18-49, 15% in females aged 50-60 years, 10% in males aged 50-60 years and 22% in individuals over the age of 70 years. 12 In the light of developing knowledge regarding the effects of both short-term and longterm COVID-19, the National Institute for Health and Care Excellence (NICE), U.K., 13 have now reassessed classification terms for illness associated with SARS-CoV-2 infections coining the terms 'Acute COVID-19' for the severe pathosis associated with primary infection, 'Ongoing Symptomatic COVID-19' for symptoms persisting for between 28 and 84 days, and 'Post-COVID-19 Syndrome' for infirmity lasting longer than 12-weeks (84-days).…”